Shaping DNA damage responses: Therapeutic potential of targeting telomeric proteins and DNA repair factors in cancer
Current Opinion in Pharmacology · 2024
DOI: 10.1016/j.coph.2024.102460 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Opinion in Pharmacology, 2024. Verfasst von Yu Bin Ng und 1 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of NFκB Signalling, Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A∗STAR), 61 Biopolis Driv…. Hauptthemen laut MEDLINE: Neoplasms, DNA Damage, DNA Repair, Antineoplastic Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 209 Literaturangaben. Gefördert von: National Medical Research Council, National Research Foundation Singapore, Agency for Science, Technology and Research.
Abstract (Originalsprache)
Shelterin proteins regulate genomic stability by preventing inappropriate DNA damage responses (DDRs) at telomeres. Unprotected telomeres lead to persistent DDR causing cell cycle inhibition, growth arrest, and apoptosis. Cancer cells rely on DDR to protect themselves from DNA lesions and exogenous DNA-damaging agents such as chemotherapy and radiotherapy. Therefore, targeting DDR machinery is a promising strategy to increase the sensitivity of cancer cells to existing cancer therapies. However, the success of these DDR inhibitors depends on other mutations, and over time, patients develop resistance to these therapies. This suggests the need for alternative approaches. One promising strategy is co-inhibiting shelterin proteins with DDR molecules, which would offset cellular fitness in DNA repair in a mutation-independent manner. This review highlights the associations and dependencies of the shelterin complex with the DDR proteins and discusses potential co-inhibition strategies that might improve the therapeutic potential of current inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of NFκB Signalling, Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A∗STAR), 61 Biopolis Drive, Proteos, Singapore 138673, Republic of Singapore.
- Laboratory of NFκB Signalling, Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A∗STAR), 61 Biopolis Drive, Proteos, Singapore 138673, Republic of Singapore. Electronic addres…
Förderung
- National Medical Research Council
- National Research Foundation Singapore
- Agency for Science, Technology and Research
- National Research Foundation
Zitieren
APA
Ng, Y. B., & Akincilar, S. C. (2024). Shaping DNA damage responses: Therapeutic potential of targeting telomeric proteins and DNA repair factors in cancer. Current Opinion in Pharmacology. https://doi.org/10.1016/j.coph.2024.102460
Vancouver
Ng YB, Akincilar SC. Shaping DNA damage responses: Therapeutic potential of targeting telomeric proteins and DNA repair factors in cancer. Current Opinion in Pharmacology. 2024. doi:10.1016/j.coph.2024.102460
BibTeX
@article{Ng2024,
author = {Ng, Yu Bin and Akincilar, Semih Can},
title = {Shaping DNA damage responses: Therapeutic potential of targeting telomeric proteins and DNA repair factors in cancer},
journal = {Current Opinion in Pharmacology},
year = {2024},
doi = {10.1016/j.coph.2024.102460}
}
EUVIMED